Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Csernok

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
Zeitschrift Fur Rheumatologie|October 5, 2001
[Presentation of the Lubeck/Bad Bramstedt Competence Center]J Rautenstrauch, A Gause, E Csernok, et al.
Biochemical and Biophysical Research Communications|February 15, 1996
Expression of the human autoantigen of Wegener's granulomatosis (PR3) in a baculovirus expression systemC H Szymkowiak, T W Johnston, E Csernok, et al.
British Journal of Rheumatology|October 1, 1996
Are antineutrophil cytoplasmic antibodies associated with spondyloarthropathies?J D Weinerth, M P Stoffel, E Csernok, et al.
International Archives of Allergy and Immunology|August 7, 1999
T cell receptor vbeta repertoire in bronchoalveolar lavage in Wegener's granulomatosis and sarcoidosisA Schnabel, H Renz, R Petermann, et al.
Clinical and Experimental Rheumatology|August 19, 2000
Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitidesU Schönermarck, E Csernok, A Trabandt, et al.
Clinical and Experimental Immunology|May 3, 2000
Granulocyte-macrophage colony-stimulating factor (GM-CSF) but not granulocyte colony-stimulating factor (G-CSF) induces plasma membrane expression of proteinase 3 (PR3) on neutrophils in vitroB Hellmich, E Csernok, A Trabandt, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Incidence and specificity of p-ANCA in rheumatic diseasesM G Braun, E Csernok, W H Schmitt, et al.
The Journal of Rheumatology|May 1, 1996
Incidence, target antigens, and clinical implications of antineutrophil cytoplasmic antibodies in rheumatoid arthritisM G Braun, E Csernok, W H Schmitt, et al.
The Open Rheumatology Journal|November 5, 2015
Diagnostic Value of Procalcitonin in ANCA-Associated Vasculitis (AAV) to Differentiate Between Disease Activity, Infection and Drug HypersensitivityK Herrmann, S Schinke, E Csernok, et al.
Clinical and Experimental Immunology|February 1, 1994
Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivoE Csernok, M Ernst, W Schmitt, et al.
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
Zeitschrift Fur Rheumatologie|October 5, 2001
[Presentation of the Lubeck/Bad Bramstedt Competence Center]J Rautenstrauch, A Gause, E Csernok, et al.
Biochemical and Biophysical Research Communications|February 15, 1996
Expression of the human autoantigen of Wegener's granulomatosis (PR3) in a baculovirus expression systemC H Szymkowiak, T W Johnston, E Csernok, et al.
British Journal of Rheumatology|October 1, 1996
Are antineutrophil cytoplasmic antibodies associated with spondyloarthropathies?J D Weinerth, M P Stoffel, E Csernok, et al.
International Archives of Allergy and Immunology|August 7, 1999
T cell receptor vbeta repertoire in bronchoalveolar lavage in Wegener's granulomatosis and sarcoidosisA Schnabel, H Renz, R Petermann, et al.
Clinical and Experimental Rheumatology|August 19, 2000
Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitidesU Schönermarck, E Csernok, A Trabandt, et al.
Clinical and Experimental Immunology|May 3, 2000
Granulocyte-macrophage colony-stimulating factor (GM-CSF) but not granulocyte colony-stimulating factor (G-CSF) induces plasma membrane expression of proteinase 3 (PR3) on neutrophils in vitroB Hellmich, E Csernok, A Trabandt, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Incidence and specificity of p-ANCA in rheumatic diseasesM G Braun, E Csernok, W H Schmitt, et al.
The Journal of Rheumatology|May 1, 1996
Incidence, target antigens, and clinical implications of antineutrophil cytoplasmic antibodies in rheumatoid arthritisM G Braun, E Csernok, W H Schmitt, et al.
The Open Rheumatology Journal|November 5, 2015
Diagnostic Value of Procalcitonin in ANCA-Associated Vasculitis (AAV) to Differentiate Between Disease Activity, Infection and Drug HypersensitivityK Herrmann, S Schinke, E Csernok, et al.
Clinical and Experimental Immunology|February 1, 1994
Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivoE Csernok, M Ernst, W Schmitt, et al.
Pageof 11